Ripudaman Singh

University Institute of Pharmaceutical Sciences (UIPS), Chandigarh University, Chandigarh, Gharuan, India

Biography

Dr. Ripudaman  Singh completed her Bachelor and Master  of Pharmacy from University of Pharmaceutical Sciences (1989-1993). She did her doctorate from Shri Venkateshwara University – India (2012-2018). She worked as an Associate Professor at Shridhar University, Pilani for 3 years. Then as a Research and Development Associate from Scientific and Applied Research Center, Meerut for more than 5 years. And now she works as an Associate Professor at Chandigarh University. 

Publications
  • Review Article   
    An Overview of World-Wide Master Key for Drug Safety Monitoring (Pharmacovigilance) and Its Role in India
    Author(s): Janmejay Pant, Harneet Marwah, Ripudaman Singh* and Subhajit Hazra

    Pharmacovigilance (PV) described as science & actions connecting to the identification, evaluation, awareness, & mitigation of Adverse Drug Reactions (ADRs) or associated conditions. Some serious cases of ADR contributed to the development of this discipline in the 1970s. There have been many efforts to establish such a programme in India between 1989-2004, but the system has finally begun in 2010 and is functioning successfully and achieving meaningful results. Based on the data gathered via this method, Pharmacovigilance Program of India (PvPI) contributed various data to the World Health Organization (WHO) Uppsala Monitoring Centre (UMC). They also issued some warnings to the stakeholder and made a range of suggestions to the Central Drugs Standard Control Organisation (CDSCO). CDSCO has also advised Marketing Permit Holders (MAHs) to comply with the same requirements and h.. View more»

    DOI: 10.35248/2329-6887.21.9.325

    Abstract HTML PDF